CN Stock MarketDetailed Quotes

600538 Beihai Gofar Chuanshan Biological

Watchlist
  • 4.08
  • -0.03-0.73%
Trading Jul 4 10:59 CST
2.14BMarket Cap-23181P/E (TTM)

Beihai Gofar Chuanshan Biological Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-13.79%87.57M
-19.69%369.15M
-16.30%283.27M
-11.41%194.25M
-15.94%101.58M
8.23%459.68M
11.09%338.43M
15.34%219.26M
28.53%120.84M
58.65%424.72M
Operating revenue
-13.79%87.57M
-19.69%369.15M
-16.30%283.27M
-11.41%194.25M
-15.94%101.58M
8.23%459.68M
11.09%338.43M
15.34%219.26M
28.53%120.84M
58.65%424.72M
Other operating revenue
----
-14.29%2.09M
----
0.52%1.28M
----
-10.81%2.44M
----
-3.74%1.28M
----
-2.30%2.73M
Total operating cost
-5.08%91.4M
-10.45%381.31M
-9.00%279.62M
-5.54%188.05M
-11.17%96.29M
4.48%425.78M
6.53%307.29M
11.58%199.08M
22.81%108.4M
58.93%407.52M
Operating cost
-9.28%68.53M
-16.29%277.46M
-13.11%214.05M
-9.36%146.21M
-16.08%75.54M
5.17%331.47M
8.73%246.34M
15.78%161.31M
30.09%90.01M
57.09%315.18M
Operating tax surcharges
-1.94%734.29K
-4.38%3.44M
-4.78%2.36M
-2.97%1.57M
-11.51%748.79K
-2.04%3.59M
5.12%2.48M
9.67%1.62M
13.42%846.19K
46.49%3.67M
Operating expense
23.29%8.48M
5.37%36.74M
-5.98%23.09M
-3.65%14.51M
4.20%6.88M
-9.48%34.87M
-8.44%24.56M
-9.35%15.06M
-17.64%6.6M
28.26%38.53M
Administration expense
1.80%12.45M
5.26%53.97M
23.80%37.37M
25.28%24.23M
24.92%12.23M
13.95%51.28M
0.47%30.18M
-2.91%19.34M
-0.50%9.79M
47.70%45M
Financial expense
37.91%-479.68K
19.59%-3.06M
-18.05%-2.36M
1.04%-1.58M
-94.59%-772.55K
4.75%-3.81M
17.73%-2M
16.06%-1.6M
65.84%-397.01K
45.09%-4M
-Interest expense (Financial expense)
-52.30%73.32K
-26.21%372.68K
-78.99%168.92K
-63.22%167.49K
-38.72%153.7K
-4.30%505.05K
564.72%803.84K
399.33%455.39K
845.85%250.84K
363.98%527.75K
-Interest Income (Financial expense)
39.17%-592.36K
24.08%-3.58M
23.62%-2.43M
19.79%-1.9M
-34.97%-973.85K
-17.82%-4.71M
-39.24%-3.18M
-12.98%-2.37M
56.46%-721.53K
46.63%-4M
Research and development
1.16%1.68M
52.27%12.76M
-10.72%5.11M
-7.35%3.1M
7.71%1.66M
-8.36%8.38M
12.06%5.73M
12.21%3.35M
-5.43%1.55M
18,139.04%9.14M
Credit Impairment Loss
----
-7.01%-5.76M
21.52%-3.88M
21.52%-3.88M
----
-91.41%-5.38M
-57.71%-4.95M
-57.71%-4.95M
----
-301.16%-2.81M
Asset Impairment Loss
-235.32%-6.43K
-5,101.97%-58.42M
61.07%-182.62K
-70.12%-182.62K
91.22%-1.92K
18.29%-1.12M
-174.81%-469.16K
-42.03%-107.35K
-93.31%-21.83K
-21.74%-1.37M
Other net revenue
-24.24%-7.4M
-882.38%-65.61M
-301.03%-17.13M
-107.56%-13.56M
-194.89%-5.96M
511.97%8.39M
330.12%8.52M
-92.39%-6.53M
-201.31%-2.02M
17.40%-2.04M
Fair value change income
----
2,767.42%7.13M
----
----
----
-90.24%-267.14K
----
----
----
---140.42K
Invest income
-23.35%-7.77M
-177.30%-9.79M
-212.24%-14.06M
-279.59%-10.23M
-152.33%-6.3M
1,888.73%12.66M
1,738.49%12.52M
-438.45%-2.7M
-218.96%-2.5M
60.93%-708.04K
-Including: Investment income associates
-22.21%-7.6M
-173.46%-9.9M
-207.47%-13.46M
-266.41%-9.88M
-149.31%-6.22M
1,321.33%13.47M
1,438.15%12.52M
-301.69%-2.7M
-218.96%-2.5M
39.15%-1.1M
Asset deal income
----
----
-100.11%-123.08
-100.11%-123.08
-100.98%-123.08
244.75%113.6K
1,891.43%114.09K
1,862.53%112.25K
1,710.54%12.5K
555.76%32.95K
Other revenue
8.99%371.66K
-48.14%1.23M
-24.16%988.68K
-32.85%744.71K
-29.62%341K
-19.79%2.38M
459.69%1.3M
505.79%1.11M
2,494.35%484.51K
150.29%2.97M
Operating profit
-1,584.87%-11.23M
-283.90%-77.76M
-133.99%-13.48M
-153.87%-7.35M
-106.40%-666.52K
178.95%42.28M
217.95%39.66M
64.75%13.65M
105.13%10.42M
71.82%15.16M
Add:Non operating Income
-63.75%56.19K
474.16%442.7K
249.14%156.1K
246.68%155K
245.58%155K
-89.73%77.11K
-94.09%44.71K
182.13%44.71K
70.77%44.85K
-31.71%751.11K
Less:Non operating expense
5,262.87%3.89K
-2.53%245.11K
-96.93%7.26K
-99.91%72.53
-99.88%72.5
107.76%251.46K
-46.31%236.83K
20.44%80.93K
2,743.92%59.66K
-65.52%121.04K
Total profit
-2,084.89%-11.18M
-284.19%-77.57M
-133.78%-13.33M
-152.88%-7.2M
-104.92%-511.59K
166.71%42.11M
208.62%39.47M
65.34%13.61M
103.87%10.41M
64.96%15.79M
Less:Income tax cost
-69.15%496.99K
-34.20%3.59M
-81.00%990.85K
-68.51%1.25M
-31.25%1.61M
-6.83%5.46M
16.24%5.21M
28.61%3.98M
74.10%2.34M
-7.99%5.86M
Net profit
FPtoL-11.67M
SL-81.16M
SL-14.33M
SL-8.45M
SL-2.12M
269.20%36.65M
312.53%34.26M
87.48%9.63M
114.52%8.06M
210.15%9.93M
Net profit from continuing operation
-450.08%-11.67M
-321.45%-81.16M
-141.82%-14.33M
-187.76%-8.45M
-126.32%-2.12M
269.20%36.65M
312.53%34.26M
87.48%9.63M
114.52%8.06M
210.15%9.93M
Less:Minority Profit
30.28%683.28K
-36.39%1.15M
-0.38%1.4M
43.44%1.3M
-20.32%524.47K
422.82%1.81M
181.51%1.41M
70.88%907.03K
235.88%658.24K
---559.8K
Net profit of parent company owners
-366.89%-12.36M
-336.23%-82.31M
-147.88%-15.73M
-211.81%-9.75M
-135.74%-2.65M
232.25%34.84M
320.93%32.85M
89.39%8.72M
74.53%7.41M
227.65%10.49M
Earning per share
Basic earning per share
-100.00%-0.02
-328.57%-0.16
-150.00%-0.03
-200.00%-0.02
-200.00%-0.01
250.00%0.07
500.00%0.06
100.00%0.02
0.00%0.01
100.00%0.02
Diluted earning per share
-100.00%-0.02
-328.57%-0.16
-150.00%-0.03
-200.00%-0.02
-200.00%-0.01
250.00%0.07
500.00%0.06
100.00%0.02
0.00%0.01
100.00%0.02
Other composite income
Total composite income
-450.08%-11.67M
-321.45%-81.16M
-141.82%-14.33M
-187.76%-8.45M
-126.32%-2.12M
269.20%36.65M
312.53%34.26M
87.48%9.63M
114.52%8.06M
210.15%9.93M
Total composite income of parent company owners
-366.89%-12.36M
-336.23%-82.31M
-147.88%-15.73M
-211.81%-9.75M
-135.74%-2.65M
232.25%34.84M
320.93%32.85M
89.39%8.72M
74.53%7.41M
227.65%10.49M
Total composite income of minority owners
30.28%683.28K
-36.39%1.15M
-0.38%1.4M
43.44%1.3M
-20.32%524.47K
422.82%1.81M
181.51%1.41M
70.88%907.03K
235.88%658.24K
---559.8K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -13.79%87.57M-19.69%369.15M-16.30%283.27M-11.41%194.25M-15.94%101.58M8.23%459.68M11.09%338.43M15.34%219.26M28.53%120.84M58.65%424.72M
Operating revenue -13.79%87.57M-19.69%369.15M-16.30%283.27M-11.41%194.25M-15.94%101.58M8.23%459.68M11.09%338.43M15.34%219.26M28.53%120.84M58.65%424.72M
Other operating revenue -----14.29%2.09M----0.52%1.28M-----10.81%2.44M-----3.74%1.28M-----2.30%2.73M
Total operating cost -5.08%91.4M-10.45%381.31M-9.00%279.62M-5.54%188.05M-11.17%96.29M4.48%425.78M6.53%307.29M11.58%199.08M22.81%108.4M58.93%407.52M
Operating cost -9.28%68.53M-16.29%277.46M-13.11%214.05M-9.36%146.21M-16.08%75.54M5.17%331.47M8.73%246.34M15.78%161.31M30.09%90.01M57.09%315.18M
Operating tax surcharges -1.94%734.29K-4.38%3.44M-4.78%2.36M-2.97%1.57M-11.51%748.79K-2.04%3.59M5.12%2.48M9.67%1.62M13.42%846.19K46.49%3.67M
Operating expense 23.29%8.48M5.37%36.74M-5.98%23.09M-3.65%14.51M4.20%6.88M-9.48%34.87M-8.44%24.56M-9.35%15.06M-17.64%6.6M28.26%38.53M
Administration expense 1.80%12.45M5.26%53.97M23.80%37.37M25.28%24.23M24.92%12.23M13.95%51.28M0.47%30.18M-2.91%19.34M-0.50%9.79M47.70%45M
Financial expense 37.91%-479.68K19.59%-3.06M-18.05%-2.36M1.04%-1.58M-94.59%-772.55K4.75%-3.81M17.73%-2M16.06%-1.6M65.84%-397.01K45.09%-4M
-Interest expense (Financial expense) -52.30%73.32K-26.21%372.68K-78.99%168.92K-63.22%167.49K-38.72%153.7K-4.30%505.05K564.72%803.84K399.33%455.39K845.85%250.84K363.98%527.75K
-Interest Income (Financial expense) 39.17%-592.36K24.08%-3.58M23.62%-2.43M19.79%-1.9M-34.97%-973.85K-17.82%-4.71M-39.24%-3.18M-12.98%-2.37M56.46%-721.53K46.63%-4M
Research and development 1.16%1.68M52.27%12.76M-10.72%5.11M-7.35%3.1M7.71%1.66M-8.36%8.38M12.06%5.73M12.21%3.35M-5.43%1.55M18,139.04%9.14M
Credit Impairment Loss -----7.01%-5.76M21.52%-3.88M21.52%-3.88M-----91.41%-5.38M-57.71%-4.95M-57.71%-4.95M-----301.16%-2.81M
Asset Impairment Loss -235.32%-6.43K-5,101.97%-58.42M61.07%-182.62K-70.12%-182.62K91.22%-1.92K18.29%-1.12M-174.81%-469.16K-42.03%-107.35K-93.31%-21.83K-21.74%-1.37M
Other net revenue -24.24%-7.4M-882.38%-65.61M-301.03%-17.13M-107.56%-13.56M-194.89%-5.96M511.97%8.39M330.12%8.52M-92.39%-6.53M-201.31%-2.02M17.40%-2.04M
Fair value change income ----2,767.42%7.13M-------------90.24%-267.14K---------------140.42K
Invest income -23.35%-7.77M-177.30%-9.79M-212.24%-14.06M-279.59%-10.23M-152.33%-6.3M1,888.73%12.66M1,738.49%12.52M-438.45%-2.7M-218.96%-2.5M60.93%-708.04K
-Including: Investment income associates -22.21%-7.6M-173.46%-9.9M-207.47%-13.46M-266.41%-9.88M-149.31%-6.22M1,321.33%13.47M1,438.15%12.52M-301.69%-2.7M-218.96%-2.5M39.15%-1.1M
Asset deal income ---------100.11%-123.08-100.11%-123.08-100.98%-123.08244.75%113.6K1,891.43%114.09K1,862.53%112.25K1,710.54%12.5K555.76%32.95K
Other revenue 8.99%371.66K-48.14%1.23M-24.16%988.68K-32.85%744.71K-29.62%341K-19.79%2.38M459.69%1.3M505.79%1.11M2,494.35%484.51K150.29%2.97M
Operating profit -1,584.87%-11.23M-283.90%-77.76M-133.99%-13.48M-153.87%-7.35M-106.40%-666.52K178.95%42.28M217.95%39.66M64.75%13.65M105.13%10.42M71.82%15.16M
Add:Non operating Income -63.75%56.19K474.16%442.7K249.14%156.1K246.68%155K245.58%155K-89.73%77.11K-94.09%44.71K182.13%44.71K70.77%44.85K-31.71%751.11K
Less:Non operating expense 5,262.87%3.89K-2.53%245.11K-96.93%7.26K-99.91%72.53-99.88%72.5107.76%251.46K-46.31%236.83K20.44%80.93K2,743.92%59.66K-65.52%121.04K
Total profit -2,084.89%-11.18M-284.19%-77.57M-133.78%-13.33M-152.88%-7.2M-104.92%-511.59K166.71%42.11M208.62%39.47M65.34%13.61M103.87%10.41M64.96%15.79M
Less:Income tax cost -69.15%496.99K-34.20%3.59M-81.00%990.85K-68.51%1.25M-31.25%1.61M-6.83%5.46M16.24%5.21M28.61%3.98M74.10%2.34M-7.99%5.86M
Net profit FPtoL-11.67MSL-81.16MSL-14.33MSL-8.45MSL-2.12M269.20%36.65M312.53%34.26M87.48%9.63M114.52%8.06M210.15%9.93M
Net profit from continuing operation -450.08%-11.67M-321.45%-81.16M-141.82%-14.33M-187.76%-8.45M-126.32%-2.12M269.20%36.65M312.53%34.26M87.48%9.63M114.52%8.06M210.15%9.93M
Less:Minority Profit 30.28%683.28K-36.39%1.15M-0.38%1.4M43.44%1.3M-20.32%524.47K422.82%1.81M181.51%1.41M70.88%907.03K235.88%658.24K---559.8K
Net profit of parent company owners -366.89%-12.36M-336.23%-82.31M-147.88%-15.73M-211.81%-9.75M-135.74%-2.65M232.25%34.84M320.93%32.85M89.39%8.72M74.53%7.41M227.65%10.49M
Earning per share
Basic earning per share -100.00%-0.02-328.57%-0.16-150.00%-0.03-200.00%-0.02-200.00%-0.01250.00%0.07500.00%0.06100.00%0.020.00%0.01100.00%0.02
Diluted earning per share -100.00%-0.02-328.57%-0.16-150.00%-0.03-200.00%-0.02-200.00%-0.01250.00%0.07500.00%0.06100.00%0.020.00%0.01100.00%0.02
Other composite income
Total composite income -450.08%-11.67M-321.45%-81.16M-141.82%-14.33M-187.76%-8.45M-126.32%-2.12M269.20%36.65M312.53%34.26M87.48%9.63M114.52%8.06M210.15%9.93M
Total composite income of parent company owners -366.89%-12.36M-336.23%-82.31M-147.88%-15.73M-211.81%-9.75M-135.74%-2.65M232.25%34.84M320.93%32.85M89.39%8.72M74.53%7.41M227.65%10.49M
Total composite income of minority owners 30.28%683.28K-36.39%1.15M-0.38%1.4M43.44%1.3M-20.32%524.47K422.82%1.81M181.51%1.41M70.88%907.03K235.88%658.24K---559.8K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg